ACALABRUTINIB Pharmacologic Class Indexing
- Class set ID
- 104ff3ed-153f-4c42-9209-69665dfc4ef6
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) capsules, for oral use Initial U.S. Approval: 2017 | AstraZeneca Pharmaceuticals LP | 20260219 | 27 |
| These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) tablets, for oral use Initial U.S. Approval: 2017 | AstraZeneca Pharmaceuticals LP | 20260219 | 8 |